Drug Research and Development

Research indicates that the vast majority of drugs at best work in 30 to 50 per cent of people.
Furthermore, side effects and toxicity are a significant issue with many promising drugs.
Using the current practice, predetermining patient profiles for treatment is limited. Trial and
error is the mainstay of drug therapies. If one drug does not work then another may.

When one mixes multiple drugs to address the multiple symptoms of a patient, with this
approach it is difficult to generate specific drug therapies achieving high efficacy with limited
to no side effects and toxicity. The future is patient specific drug therapies to achieve high
efficacy and success. Read more..